The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model
Open accessAbstract
Tumor microenvironment is characterized by chronic inflammation represented by infiltrating leukocytes and soluble mediators, which lead to a local and systemic immunosuppression associated with cancer progression. Here, we used the ret transgenic spontaneous murine melanoma model that mimics human melanoma. Skin tumors and metastatic lymph nodes showed increased levels of inflammatory factors such as IL-1β, GM-CSF, and IFN-γ, which correlated with tumor progression. Moreover, Gr1 + CD11b + myeloid-derived suppressor cells (MDSCs), known to inhibit tumor reactive T cells, were enriched in melanoma lesions and lymphatic organs during tumor progression. MDSC infiltration was associated with a strong TCR ζ-chain down-regulation in all T cells. Coculturing normal splenocytes with tumor-derived MDSC induced a decreased T-cell proliferation and ζ-chain expression, verifying the MDSC immunosuppressive function and suggesting that the tumor inflammatory microenvironment supports MDSC recruitment and immunosuppressive activity. Indeed, upon manipulation of the melanoma microenvironment with the phosphodiesterase-5 inhibitor sildenafil, we observed reduced levels of numerous inflammatory mediators (e.g., IL-1β, IL-6, VEGF, S100A9) in association with decreased MDSC amounts and immunosuppressive function, indicating an antiinflammatory effect of sildenafil. This led to a partial restoration of ζ-chain expression in T cells and to a significantly increased survival of tumor-bearing mice. CD8 T-cell depletion resulted in an abrogation of sildenafil beneficial outcome, suggesting the involvement of MDSC and CD8 T cells in the observed therapeutic effects. Our data imply that inhibition of chronic inflammation in the tumor microenvironment should be applied in conjunction with melanoma immunotherapies to increase their efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Regulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775
Research works printed but not linked: 43
- 10.1097/CCO.0b013e328337fe8f · DOI
- 10.1016/S0065-230X(03)90005-4 · DOI
- 10.1097/CCO.0b013e32801497d7 · DOI
- 10.1146/annurev.immunol.24.021605.090733 · DOI · Paper page
- 10.1111/j.1755-148X.2009.00634.x · DOI
- 10.1016/j.semcancer.2005.12.002 · DOI
- 10.1016/j.coi.2007.01.001 · DOI · Paper page
- 10.4049/jimmunol.0802740 · DOI · Paper page
- 10.1016/j.imbio.2009.06.014 · DOI · Paper page
- 10.1016/j.semcancer.2005.07.005 · DOI · Paper page
- 10.1007/s10555-006-9002-6 · DOI · Paper page
- 10.1172/JCI28828 · DOI · Paper page
- 10.1007/s00262-010-0855-8 · DOI · Paper page
- 10.1016/j.semcancer.2005.10.001 · DOI
- 10.1034/j.1600-065X.2002.18809.x · DOI · Paper page
- 10.4049/jimmunol.177.7.4763 · DOI · Paper page
- 10.1074/jbc.M110675200 · DOI · Paper page
- 10.1038/nri1434 · DOI · Paper page
- 10.1016/j.coph.2009.06.014 · DOI · Paper page
- 10.1038/nrd2030 · DOI · Paper page
- 10.1084/jem.20061104 · DOI · Paper page
- 10.1158/0008-5472.CAN-07-6621 · DOI · Paper page
- 10.1186/1471-2172-10-1 · DOI
- 10.1038/sj.onc.1202077 · DOI · Paper page
- 10.1158/0008-5472.CAN-08-1464 · DOI
- 10.1016/S1535-6108(02)00161-7 · DOI · Paper page
- 10.1158/1078-0432.CCR-09-0399 · DOI
- 10.1182/blood-2008-03-143776 · DOI
- 10.4049/jimmunol.181.8.5791 · DOI · Paper page
- 10.1016/j.coi.2010.01.021 · DOI · Paper page
- 10.1016/S1350-9462(02)00013-7 · DOI
- 10.1016/j.immuni.2010.05.010 · DOI · Paper page
- 10.1038/ni975 · DOI
- 10.1200/JCO.2006.08.5829 · DOI · Paper page
- 10.1158/0008-5472.CAN-09-3767 · DOI · Paper page
- 10.1182/blood-2003-01-0190 · DOI · Paper page
- 10.4049/jimmunol.176.1.284 · DOI · Paper page
- 10.1038/nri1498 · DOI · Paper page
- 10.1111/j.1600-065X.2008.00602.x · DOI · Paper page
- 10.1002/cncr.10346 · doi:10.1002/cncr.10346
- 10.1007/s00262-004-0521-0 · DOI
- 10.1084/jem.20080132 · DOI · Paper page
- 10.4049/jimmunol.181.7.4666 · DOI · Paper page
Cited by
How the ageing microenvironment influences tumour progression
Fane, M., & Weeraratna, A. T. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0222-9 · Cited by 849
Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
Groth, C., Hu, X., Weber, R., Fleming, V., Altevogt, P., Utikal, J., & Umansky, V. (2019) · British Journal of Cancer · doi:10.1038/s41416-018-0333-1 · Cited by 839
Self-citationLindau, D., Gielen, P., Kroesen, M., Wesseling, P., & Adema, G. J. (2013) · Immunology · doi:10.1111/imm.12036 · Cited by 815
Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
Weber, R., Fleming, V., Hu, X., Nagibin, V., Groth, C., Altevogt, P., Utikal, J., & Umansky, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01310 · Cited by 538
Self-citationErin, N., Grahovac, J., Brozovic, A., & Efferth, T. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100715 · Cited by 527
Metadata
- Authors
- Meyer, C., Sevko, A., Ramacher, M., Bazhin, A. V., Falk, C. S., Osen, W., Borrello, I., Kato, M., Schadendorf, D., Baniyash, M., & Umansky, V.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2011-10-03
- Volume
- 108
- Issue
- 41
- Pages
- 17111-17116
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2093504658
- Cited by
- 346
- References
- 3
- FWCI
- 12.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model. https://app.cochat.ai/papers/10.1073/pnas.1108121108
- The paper
- Meyer, C., Sevko, A., Ramacher, M., Bazhin, A. V., Falk, C. S., Osen, W., Borrello, I., Kato, M., Schadendorf, D., Baniyash, M., & Umansky, V. (2011). Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1108121108
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.